The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Implements the Goldilocks adaptive trial design for a time to event outcome using a piecewise exponential model and conjugate Gamma prior distributions. The method closely follows the article by Broglio and colleagues <doi:10.1080/10543406.2014.888569>, which allows users to explore the operating characteristics of different trial designs.
Version: | 0.4.0 |
Depends: | R (≥ 3.6.0), survival |
Imports: | dplyr, parallel, pbmcapply, PWEALL, Rcpp, rlang, stats |
LinkingTo: | BH, Rcpp |
Suggests: | covr, testthat (≥ 3.0.0), knitr, rmarkdown |
Published: | 2025-01-08 |
DOI: | 10.32614/CRAN.package.goldilocks |
Author: | Graeme L. Hickey [aut, cre], Ying Wan [aut], Thevaa Chandereng [aut] (bayesDP code as a template), Becton, Dickinson and Company [cph], Tim Kacprowski [ctb] (For code from fastlogrank R package.) |
Maintainer: | Graeme L. Hickey <graemeleehickey at gmail.com> |
BugReports: | https://github.com/graemeleehickey/goldilocks/issues |
License: | GPL-3 |
URL: | https://github.com/graemeleehickey/goldilocks |
NeedsCompilation: | yes |
Language: | en-US |
Materials: | README NEWS |
CRAN checks: | goldilocks results |
Reference manual: | goldilocks.pdf |
Vignettes: |
Example: Two-armed RCT (source, R code) |
Package source: | goldilocks_0.4.0.tar.gz |
Windows binaries: | r-devel: goldilocks_0.4.0.zip, r-release: goldilocks_0.4.0.zip, r-oldrel: goldilocks_0.4.0.zip |
macOS binaries: | r-release (arm64): goldilocks_0.4.0.tgz, r-oldrel (arm64): goldilocks_0.4.0.tgz, r-release (x86_64): goldilocks_0.4.0.tgz, r-oldrel (x86_64): goldilocks_0.4.0.tgz |
Old sources: | goldilocks archive |
Please use the canonical form https://CRAN.R-project.org/package=goldilocks to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.